Cormorant Asset Management’s Minerva Neurosciences NERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $167K | Sell |
|
|||||
|
2021
Q2 | $570K | Buy |
|
|||||
|
2021
Q1 | $584K | Hold |
|
|||||
|
2020
Q4 | $468K | Sell |
|
|||||
|
2020
Q3 | $759K | Sell |
|
|||||
|
2020
Q2 | $1.85M | Sell |
|
|||||
|
2020
Q1 | $3.66M | Hold |
|
|||||
|
2019
Q4 | $4.32M | Hold |
|
|||||
|
2019
Q3 | $4.71M | Hold |
|
|||||
|
2019
Q2 | $3.42M | Hold |
|
|||||
|
2019
Q1 | $4.78M | Hold |
|
|||||
|
2018
Q4 | $4.1M | Hold |
|
|||||
|
2018
Q3 | $7.63M | Hold |
|
|||||
|
2018
Q2 | $5.01M | Hold |
|
|||||
|
2018
Q1 | $3.8M | Hold |
|
|||||
|
2017
Q4 | $3.68M | Hold |
|
|||||
|
2017
Q3 | $4.62M | Sell |
|
|||||
|
2017
Q2 | $17.7M | Sell |
|
|||||
|
2017
Q1 | $18.7M | Sell |
|
|||||
|
2016
Q4 | $31.2M | Sell |
|
|||||
|
2016
Q3 | $39.5M | Hold |
|
|||||
|
2016
Q2 | $28.6M | Buy |
|
|||||
|
2016
Q1 | $10.8M | Buy |
|
|||||
|
2015
Q4 | $6.95M | Hold |
|
|||||
|
2015
Q3 | $6.01M | Sell |
|
|||||
|
2015
Q2 | $6.64M | Buy |
|
|||||
|
2015
Q1 | $5.72M | Buy |
|
|||||
|
2014
Q4 | $1.05M | Hold |
|
|||||
|
2014
Q3 | $1.06M | Buy |
|